Published in Gastroenterology on October 01, 2001
Inflammation, atrophy, and gastric cancer. J Clin Invest (2007) 4.29
Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev (2010) 3.41
Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res (2008) 2.08
A molecular signature of gastric metaplasia arising in response to acute parietal cell loss. Gastroenterology (2007) 1.88
Cellular and molecular aspects of gastric cancer. World J Gastroenterol (2006) 1.84
Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev (2006) 1.73
Cancer and inflammation: promise for biologic therapy. J Immunother (2010) 1.72
A revised annotation and comparative analysis of Helicobacter pylori genomes. Nucleic Acids Res (2003) 1.59
Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia. Am J Pathol (2005) 1.51
A novel genetic polymorphism of inducible nitric oxide synthase is associated with an increased risk of gastric cancer. World J Gastroenterol (2004) 1.40
Helicobacter Pylori associated global gastric cancer burden. Front Biosci (Landmark Ed) (2009) 1.33
Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett (2008) 1.29
Multifactorial etiology of gastric cancer. Methods Mol Biol (2012) 1.29
Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut (2003) 1.22
Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis. Br J Cancer (2008) 1.18
Genetic variation in the prostate stem cell antigen gene and upper gastrointestinal cancer in white individuals. Gastroenterology (2010) 1.18
Gastric cancer and H. pylori: Host genetics open the way. Gastroenterology (2001) 1.12
Cytokine genetic polymorphisms and prostate cancer aggressiveness. Carcinogenesis (2009) 1.09
Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbils. Cancer Sci (2009) 1.09
Higher number of Helicobacter pylori CagA EPIYA C phosphorylation sites increases the risk of gastric cancer, but not duodenal ulcer. BMC Microbiol (2011) 1.05
Interleukin-1 and TNF-alpha polymorphisms and Helicobacter pylori in a Brazilian Amazon population. World J Gastroenterol (2009) 1.04
Inflammasomes in cancer: a double-edged sword. Protein Cell (2014) 1.01
Multidisciplinary approach to understand the pathogenesis of gastric cancer. World J Gastroenterol (2005) 1.01
Systematic review and meta-analysis on the association between IL-1B polymorphisms and cancer risk. PLoS One (2013) 0.99
Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer. World J Gastroenterol (2010) 0.97
Association of gastric disease with polymorphisms in the inflammatory-related genes IL-1B, IL-1RN, IL-10, TNF and TLR4. Eur J Gastroenterol Hepatol (2009) 0.95
The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis. Front Cell Infect Microbiol (2012) 0.94
Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pylori. J Gastroenterol Hepatol (2009) 0.92
Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk. Br J Cancer (2005) 0.91
Host factors are important in determining clinical outcomes of Helicobacter pylori infection. J Gastroenterol (2006) 0.91
Transgenic expression of interferon-γ in mouse stomach leads to inflammation, metaplasia, and dysplasia. Am J Pathol (2012) 0.90
Association of interleukin 1 gene family polymorphisms with duodenal ulcer disease. Clin Exp Immunol (2003) 0.90
P27kip1 regulates the apoptotic response of gastric epithelial cells to Helicobacter pylori. Gut (2004) 0.88
Polymorphisms in interleukin-1B (IL-1B) and interleukin 1 receptor antagonist (IL-1RN) genes associate with gastric cancer risk in the Chinese population. Dig Dis Sci (2011) 0.88
Effect of IL-1β and TNF-α polymorphisms on the prognosis and survival of gastric cancer patients. Clin Exp Med (2011) 0.88
Interleukin-1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms and gastric cancer risk in an Omani Arab population. Gastric Cancer (2006) 0.87
Role of host interleukin 1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in clinical outcomes in Helicobacter pylori-positive Turkish patients with dyspepsia. J Gastroenterol (2008) 0.87
A novel method for genotyping the Helicobacter pylori vacA intermediate region directly in gastric biopsy specimens. J Clin Microbiol (2012) 0.87
Causes and consequences of microsatellite instability in gastric carcinogenesis. World J Gastroenterol (2014) 0.86
Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan. J Gastroenterol Hepatol (2014) 0.86
Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms. World J Gastroenterol (2006) 0.86
Effect of interlukin-1beta on proliferation of gastric epithelial cells in culture. BMC Gastroenterol (2002) 0.86
Pathogenesis of Helicobacter pylori infection. Springer Semin Immunopathol (2005) 0.85
Association between Helicobacter pylori cagA-related genes and clinical outcomes in Colombia and Japan. BMC Gastroenterol (2011) 0.85
A functional polymorphism in the interleukin-1 receptor-1 gene is associated with increased risk of Helicobacter pylori infection but not with gastric cancer. Dig Dis Sci (2004) 0.84
Causal role of Helicobacter pylori infection in gastric cancer. World J Gastroenterol (2006) 0.84
Genetic screening for familial gastric cancer. Hered Cancer Clin Pract (2004) 0.83
Variable number of tandem repeat polymorphisms of the interleukin-1 receptor antagonist gene IL-1RN: a novel association with the athlete status. BMC Med Genet (2010) 0.83
Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. World J Gastroenterol (2006) 0.82
Challenges of deciphering gastric cancer heterogeneity. World J Gastroenterol (2015) 0.82
Th1/Th2 cytokines and their genotypes as predictors of hepatitis B virus related hepatocellular carcinoma. World J Hepatol (2015) 0.82
Interleukin10 -592 promoter polymorphism associated with gastric cancer among Asians: a meta-analysis of epidemiologic studies. Dig Dis Sci (2009) 0.82
Association of tumor necrosis factor genetic polymorphism with chronic atrophic gastritis and gastric adenocarcinoma in Chinese Han population. World J Gastroenterol (2004) 0.81
IL-1B -31T>C promoter polymorphism is associated with gastric stump cancer but not with early onset or conventional gastric cancers. Virchows Arch (2008) 0.81
No relationship between IL-1B gene polymorphism and gastric acid secretion in younger healthy volunteers. World J Gastroenterol (2005) 0.81
Relationship between IL-1beta gene polymorphism and gastric mucosal IL-1beta levels in patients with Helicobacter pylori infection. J Gastroenterol (2005) 0.81
Taurolidine reduces the tumor stimulating cytokine interleukin-1beta in patients with resectable gastrointestinal cancer: a multicentre prospective randomized trial. World J Surg Oncol (2009) 0.80
Role of tumor necrosis factor-α -308 G/A promoter polymorphism in gastric cancer. Saudi J Gastroenterol (2013) 0.80
Infection with specific Helicobacter pylori-cag pathogenicity island strains is associated with interleukin-1B gene polymorphisms in Venezuelan chronic gastritis patients. Dig Dis Sci (2010) 0.80
IL-1B-511 Allele T and IL-1RN-L/L Play a Pathological Role in Helicobacter Pylori (H. Pylori) Disease Outcome in the African Population. Ethiop J Health Sci (2012) 0.80
Association of haplotypes of inflammation-related genes with gastric preneoplastic lesions in African Americans and Caucasians. Int J Cancer (2011) 0.80
Associations between interleukin-1 polymorphisms and gastric cancers among three ethnicities. World J Gastroenterol (2012) 0.79
To be or not to be: The host genetic factor and beyond in Helicobacter pylori mediated gastro-duodenal diseases. World J Gastroenterol (2015) 0.79
Interleukin-1 beta single-nucleotide polymorphism's C allele is associated with elevated risk of gastric cancer in Helicobacter pylori-infected Peruvians. Am J Trop Med Hyg (2009) 0.79
Interleukin-4 receptor -3223T→C polymorphism is associated with increased gastric adenocarcinoma risk. Can J Gastroenterol (2012) 0.79
Glutathione S-transferase M1 null genotype associated with gastric cancer among Asians. Dig Dis Sci (2009) 0.79
Polymorphisms of thymidylate synthase in the 5'- and 3'-untranslated regions and gastric cancer. Dig Dis Sci (2008) 0.78
Interleukin-1B signalling leads to increased survival of gastric carcinoma cells through a CREB-C/EBPβ-associated mechanism. Gastric Cancer (2015) 0.78
Role of interleukin polymorphisms in gastric cancer: "Pros and cons". World J Gastrointest Oncol (2010) 0.78
A possible role of IL-1RN gene polymorphism in the outcome of gastrointestinal diseases associated with H. pylori infection. Clin Exp Gastroenterol (2013) 0.78
First-degree relatives of early-onset gastric cancer patients show a high risk for gastric cancer: phenotype and genotype profile. Virchows Arch (2013) 0.77
The influence of cytokine gene polymorphisms on the risk of developing gastric cancer in patients with Helicobacter pylori infection. Radiol Oncol (2015) 0.77
A comparison study of gastric cancer risk in patients with duodenal and gastric ulcer: roles of gastric mucosal histology and p53 codon 72 polymorphism. Dig Dis Sci (2004) 0.77
Familial Clustering of Gastric Cancer: A Retrospective Study Based on the Number of First-Degree Relatives. Medicine (Baltimore) (2016) 0.76
Effect of IL-1β and IL-1RN polymorphisms in carcinogenesis of the gastric mucosa in patients infected with Helicobacter pylori in Algeria. Libyan J Med (2016) 0.76
The IL1B-511 Polymorphism (rs16944 AA Genotype) Is Increased in Aspirin-Exacerbated Respiratory Disease in Mexican Population. J Allergy (Cairo) (2011) 0.76
Interleukin-1 gene polymorphisms in chronic gastritis patients infected with Helicobacter pylori as risk factors of gastric cancer development. Arch Immunol Ther Exp (Warsz) (2013) 0.76
Helicobacter pylori from gastric cancer and duodenal ulcer show same phylogeographic origin in the Andean region in Colombia. PLoS One (2014) 0.75
Inflammation, DNA Damage, Helicobacter pylori and Gastric Tumorigenesis. Front Genet (2017) 0.75
Regulation of Gastric Carcinogenesis by Inflammatory Cytokines. Cell Mol Gastroenterol Hepatol (2017) 0.75
Eradication of H pylori for the prevention of gastric cancer. World J Gastroenterol (2006) 0.75
Lack of genetic influence on the innate inflammatory response to helicobacter infection of the gastric mucosa. Front Immunol (2012) 0.75
Gender-related distribution of the interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in patients with end-stage liver disease. Inflammation (2010) 0.75
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
Y-chromosomal diversity in Europe is clinal and influenced primarily by geography, rather than by language. Am J Hum Genet (2000) 4.72
Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology (1998) 4.11
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res (1995) 3.33
Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med (2001) 3.27
A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene (2006) 3.21
Fetal loss, gravidity, and pregnancy order. Early Hum Dev (1978) 3.06
Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology (2001) 3.00
Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. Breast (2008) 2.96
Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet (2004) 2.95
Mutations truncating the EP300 acetylase in human cancers. Nat Genet (2000) 2.84
p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res (1994) 2.80
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch (2008) 2.78
Typing of Helicobacter pylori vacA gene and detection of cagA gene by PCR and reverse hybridization. J Clin Microbiol (1998) 2.77
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol (1998) 2.73
Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res (1993) 2.48
Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene (2011) 2.42
Arthrogryposis multiplex congenita with renal and hepatic abnormalities in a female infant. J Pediatr (1990) 2.41
Familial gastric cancer: overview and guidelines for management. J Med Genet (1999) 2.38
Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. Br J Cancer (1999) 2.36
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer (2011) 2.28
Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res (1998) 2.20
Conservation. High value and long life--double jeopardy for tunas and billfishes. Science (2011) 2.14
Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. Gut (2011) 2.14
Allelotype of pancreatic adenocarcinoma. Cancer Res (1994) 2.11
Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer (1998) 2.09
Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res (1999) 2.09
KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression. Oncogene (2006) 2.07
Relationship between surface area for adhesion and tensile bond strength--evaluation of a micro-tensile bond test. Dent Mater (1994) 2.03
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received. Br J Cancer (2010) 1.99
Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin. J Pathol (2007) 1.91
Nature meets nurture: molecular genetics of gastric cancer. Hum Genet (2009) 1.87
Triple negative breast cancers: clinical and prognostic implications. Eur J Cancer (2009) 1.83
Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients. Br J Cancer (2009) 1.82
Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis. Inflamm Bowel Dis (2008) 1.78
Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers. Oncogene (2006) 1.74
Prehistoric and historic traces in the mtDNA of Mozambique: insights into the Bantu expansions and the slave trade. Ann Hum Genet (2001) 1.74
A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol (1998) 1.70
Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer (1997) 1.69
Online reference database of European Y-chromosomal short tandem repeat (STR) haplotypes. Forensic Sci Int (2001) 1.67
Papillary and mucoepidermoid carcinoma of the thyroid with anaplastic transformation: a case report with histologic and immunohistochemical findings that support a provocative histogenetic hypothesis. Pathol Res Pract (1995) 1.65
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Issues of consent and feedback in a genetic epidemiological study of women with breast cancer. J Med Ethics (2003) 1.55
E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene (2001) 1.54
Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol (2001) 1.51
Hospital outbreak of Salmonella virchow possibly associated with a food handler. J Hosp Infect (2000) 1.51
Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologic implications and prognosis. Gastroenterology (1996) 1.51
"Is bipolar disorder an endocrine condition?" Glucose abnormalities in bipolar disorder. Acta Psychiatr Scand (2013) 1.50
Low molecular weight protein tyrosine phosphatase genetic polymorphism and susceptibility to cancer development. Cancer Genet Cytogenet (2008) 1.48
Mutation rates at Y chromosome specific microsatellites. Hum Mutat (2005) 1.48
E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest (1999) 1.47
High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation. Oncogene (2006) 1.46
PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab (2005) 1.46
Loss of Y chromosome in gastric carcinoma. Fact or artifact? Cancer Genet Cytogenet (1992) 1.45
Distinct variants of Helicobacter pylori cagA are associated with vacA subtypes. J Clin Microbiol (1999) 1.43
Prenatal sonographic diagnosis of a rare Cantrell's pentalogy variant with associated open neural tube defect - a case report. Fetal Diagn Ther (2007) 1.43
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology (1994) 1.41
Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis. Gut (2008) 1.41
Expression of angiogenic factors during distraction osteogenesis. Bone (2003) 1.39
Bilateral papillitis in ocular toxoplasmosis. Eye (Lond) (2009) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J Cancer (2005) 1.39
Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. J Med Genet (2004) 1.38
Prophylactic total gastrectomy for familial gastric cancer. Surgery (2001) 1.37
Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening. Br J Cancer (2009) 1.36
Evidence for a role of FGF-2 and FGF receptors in the proliferation of non-small cell lung cancer cells. Int J Cancer (1999) 1.36
Molecular cytogenetic analysis of breast cancer cell lines. Br J Cancer (2000) 1.36
MLL2, the second human homolog of the Drosophila trithorax gene, maps to 19q13.1 and is amplified in solid tumor cell lines. Oncogene (1999) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
MUC1 gene polymorphism and gastric cancer--an epidemiological study. Glycoconj J (1997) 1.32